This is a preview of subscription content, log in via an institution to check access.
Literatur
Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med 1995; 333: 764–9.
Darius H, Veit K, Rupprecht HJ. Synergistic inhibition of platelet aggregation by ticlopidine plus aspirin following intracoronary stent placement. Circulation 1996; 94: Suppl 1: 1–257.
Rupprecht HJ, Darius H, Voigtländer T, et al. Ticlopidine, aspirin or both after stent implantation? Circulation 1996; 94: Suppl 1: 1–257.
Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084–9.
Serruys PW, Herrman JP, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. N Engl J Med 1995; 333: 757–63.
The CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 2: 1329–39.
The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in highrisk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994; 330: 956–61.
The GUSTO-IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775–82.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rupprecht, HJ. Neue Konzepte in der Prävention der Atherothrombose. Herz 23, 205–207 (1998). https://doi.org/10.1007/BF03044609
Issue Date:
DOI: https://doi.org/10.1007/BF03044609